相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion
Lingling Si et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism
Shuangyan Ye et al.
CELL DEATH & DISEASE (2020)
Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity
Dominique Delmas et al.
MOLECULES (2020)
Cadmium exposure activates Akt/ERK Signaling and pro-inflammatory COX-2 expression in human gallbladder epithelial cells via a ROS dependent mechanism
Priyanka Sharma et al.
TOXICOLOGY IN VITRO (2020)
Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer
Dong Chen et al.
CANCER DISCOVERY (2019)
Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Erika S. Dahl et al.
MOLECULAR CANCER RESEARCH (2019)
Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
Elisa Bergaggio et al.
CANCERS (2019)
The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13
Yan Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Silybin and metabolic disorders
Pasquale Pignatelli et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms
Xi Su et al.
THERANOSTICS (2019)
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou et al.
BMC CANCER (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
ROS signalling in the biology of cancer
Jennifer N. Moloney et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Cancer of the ovary, fallopian tube, and peritoneum
Jonathan S. Berek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Dan Ye et al.
TRENDS IN CANCER (2018)
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
Daniel R. Wahl et al.
CANCER RESEARCH (2017)
Subcellular localization of the FLT3-ITD oncogene plays a significant role in the production of NOX- and p22phox-derived reactive oxygen species in acute myeloid leukemia
Jennifer N. Moloney et al.
LEUKEMIA RESEARCH (2017)
Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
Andrea E. Calvert et al.
CELL REPORTS (2017)
Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP+/NADPH ratio
M. Itsumi et al.
CELL DEATH AND DIFFERENTIATION (2015)
Target Identification of Grape Seed Extract in Colorectal Cancer Using Drug Affinity Responsive Target Stability (DARTS) Technique: Role of Endoplasmic Reticulum Stress Response Proteins
Molly M. Derry et al.
CURRENT CANCER DRUG TARGETS (2014)
A novel approach for the efficient extraction of silybin from milk thistle fruits
Caihong Tan et al.
PHARMACOGNOSY MAGAZINE (2014)
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Simran S. Sabharwal et al.
NATURE REVIEWS CANCER (2014)
Silibinin Inhibits Tumor Growth through Downregulation of Extracellular Signal-Regulated Kinase and Akt in Vitro and in Vivo in Human Ovarian Cancer Cells
Hyun Jin Cho et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors
Kazem Nejati-Koshki et al.
CYTOTECHNOLOGY (2012)
Chemistry and biology of reactive oxygen species in signaling or stress responses
Bryan C. Dickinson et al.
NATURE CHEMICAL BIOLOGY (2011)
Silybin and the liver: From basic research to clinical practice
Carmela Loguercio et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
Fonnet E. Bleeker et al.
ACTA NEUROPATHOLOGICA (2010)
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
R. J. DeBerardinis et al.
ONCOGENE (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Silibinin Inhibits Glioma Cell Proliferation via Ca2+/ROS/MAPK-Dependent Mechanism In Vitro and Glioma Tumor Growth In Vivo
Kwang Won Kim et al.
NEUROCHEMICAL RESEARCH (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis
Veronique Nogueira et al.
CANCER CELL (2008)
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin
Rana P. Singh et al.
CLINICAL CANCER RESEARCH (2008)
Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes
Dominique Detaille et al.
LIFE SCIENCES (2008)
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Regulation of singlet oxygen-induced apoptosis by cytosolic NADP+-dependent isocitrate dehydrogenase
Sun Yee Kim et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Silymarin as a new hepatoprotective agent in experimental cholestasis: New possibilities for an ancient medication
FA Crocenzi et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation
M Plísková et al.
TOXICOLOGY (2005)
Mechanisms that regulate production of reactive oxygen species by cytochrome P450
RC Zangar et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Silymarin is a selective estrogen receptor β (ERβ) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats
D Seidlová-Wuttke et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
分享论文
